Loading...
•
Jun 30, 2020
Health Catalyst Q2 2020 Earnings Report
Reported financial results, outperforming revenue and Adjusted EBITDA guidance, and team member satisfaction ranked in the 99th percentile.
Key Takeaways
Health Catalyst reported strong financial results for Q2 2020, exceeding revenue and Adjusted EBITDA guidance. Team member satisfaction remained high, and the company is hosting its annual Healthcare Analytics Summit virtually in September.
Total revenue for the quarter ended June 30, 2020, was $43.259 million, an 18% increase year-over-year.
Technology revenue increased by 27% year-over-year, reaching $25.487 million.
The company's team member overall satisfaction score ranked in the 99th percentile.
Health Catalyst is hosting its seventh annual Healthcare Analytics Summit in September, focusing on healthcare analytics in the 'new normal'.
Health Catalyst
Health Catalyst
Forward Guidance
Health Catalyst provides forward-looking guidance on total revenue and Adjusted EBITDA. For the third quarter of 2020, the company expects total revenue between $43.0 million and $46.0 million, and Adjusted EBITDA between $(8.9) million and $(6.9) million. For the full year of 2020, the company expects total revenue between $177.2 million and $181.2 million, and Adjusted EBITDA between $(25.5) million and $(22.5) million.
Positive Outlook
- Total revenue between $43.0 million and $46.0 million for Q3 2020
- Adjusted EBITDA between $(8.9) million and $(6.9) million for Q3 2020
- Total revenue between $177.2 million and $181.2 million for the full year 2020
- Adjusted EBITDA between $(25.5) million and $(22.5) million for the full year 2020